MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0055741
Nyasa Pharma Private Limited
Nyasa Pharma Private Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.97 Cr
▼ 38% YoY
Net profit · FY 2025
₹2.74 Lakh
Net margin 1.4%
EBITDA · FY 2025
₹3.92 Lakh
EBITDA margin 2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Nyasa Pharma Private Limited
Data last updated:
Nyasa Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 08 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2014PTC092228. Its GSTIN is 36AAECN5758P1ZO (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kadiyala Venkata Naga Parvateesa Sai Chandra and Sri Varshini Garimella.
Its last annual general meeting (AGM) was held on 05 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D.No:2 – 17 – 76/2/17 Raghavendra Nagar Colony Kalyanapuri Uppal, Hyderabad, Telangana, India – 500039.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.97 Cr, a decline of 38% compared to the previous year. For the same year it recorded a net profit of ₹2.74 Lakh (net margin 1.4%) and EBITDA of ₹3.92 Lakh (EBITDA margin 2%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 20% over five years.
Court records list 1 case involving the company, including 1 filed by the company.
Nyasa Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0055741). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233TG2014PTC092228
Registration Number 092228
Incorporation Date 08 January 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 05 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0055741
CIN history
Nyasa Pharma has one previous CIN (Corporate Identification Number): U24233AP2014PTC092228. The current CIN is U24233TG2014PTC092228, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2014PTC092228 | Current |
| U24233AP2014PTC092228 | Previous |
Recognitions & Rankings of Nyasa Pharma
Contact details
Nyasa Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD.No:2 – 17 – 76/2/17 Raghavendra Nagar Colony Kalyanapuri Uppal, Hyderabad, Telangana, India – 500039
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Nyasa Pharma Private Limited, buy the company report.
Comprehensive company report
Nyasa Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nyasa Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nyasa Pharma Private Limited, buy the company report.
Financials of Nyasa Pharma Private Limited
FY 2025 filings availableNyasa Pharma Private Limited reported revenue of ₹1.97 Cr (down 38% YoY) for FY 2025.
Revenue · FY 2025
₹1.97 Cr ▼ 38%
Net profit · FY 2025
₹2.74 Lakh margin 1.4%
EBITDA · FY 2025
₹3.92 Lakh margin 2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 38%
3 years · compounded
▼ 29%
5 years · compounded
▼ 20%
EBITDA CAGR growth
1 year
▼ 35%
3 years · compounded
▼ 7%
5 years · compounded
▲ 12%
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 38% fall in the latest year. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.74 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nyasa Pharma Private Limited, buy the company report.
Board of directors of Nyasa Pharma Private Limited
Nyasa Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kadiyala Venkata Naga Parvateesa Sai Chandra | Director | 22 Nov 2018 | 7 Years 11 Months | Current |
| Sri Varshini Garimella | Director | 17 Jan 2025 | 1 Years 9 Months | Current |
Auditor
Nyasa Pharma Private Limited is audited by VINODH J & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINODH J & CO | FY 2022 | 017647S |
Shareholding
The shareholding of Nyasa Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nyasa Pharma Private Limited, buy the company report.
Legal cases
Nyasa Pharma Private Limited has 1 court case on record: 1 filed by Nyasa Pharma. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Writ petition | Filed by the company against The Assistant Commissioner (St) and 1 other | Disposed |
To see the full case history of Nyasa Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nyasa Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nyasa Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECN5758P1ZO | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nyasa Pharma Private Limited, buy the company report.
Recent activity
Nyasa Pharma Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Kadiyala Venkata Satya Narayana ceased to be Director on 17 Jan 2025.
AGM
Nyasa Pharma Private Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records.
Filing
Nyasa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Kadiyala Venkata Satya Narayana ceased to be Director.
Appointed
Sri Varshini Garimella was appointed as Director.
Ceased
Kadiyala Ravi Kanth ceased to be Director.
Appointed
Kadiyala Venkata Naga Parvateesa Sai Chandra was appointed as Director.
Ceased
Shaik Alli ceased to be Director.
Appointed
Kadiyala Venkata Satya Narayana was appointed as Director.
Incorporation
08 Jan 2014
Nyasa Pharma Private Limited was registered on 08 Jan 2014 with Roc Hyderabad & aged 12 years 9 months as per MCA records.
Frequently asked questions
Nyasa Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 08 January 2014 (12+ years old) and is registered under CIN U24233TG2014PTC092228.
Nyasa Pharma has 2 current directors:
- Kadiyala Venkata Naga Parvateesa Sai Chandra - Director
- Sri Varshini Garimella - Director
The latest financial statements of Nyasa Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 05 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nyasa Pharma is 36AAECN5758P1ZO, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Nyasa Pharma is U24233TG2014PTC092228. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nyasa Pharma has 1 court case on record: 1 filed by the company.
Nyasa Pharma was incorporated on 08 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Kadiyala Venkata Satya Narayana ceased to be Director on 17 Jan 2025. Sri Varshini Garimella was appointed as Director on 17 Jan 2025. Kadiyala Ravi Kanth ceased to be Director on 18 Nov 2020. Nyasa Pharma has 6 board changes on record in total.
Yes, Nyasa Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0055741).
The registered office of Nyasa Pharma is at D.No:2 – 17 – 76217 Raghavendra Nagar Colony Kalyanapuri Uppal, Hyderabad, Telangana, India – 500039.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages